Skip to main content
logo
GenSight Biologics S.A. (EPA:SIGHT)
France flag France · Delayed Price · Currency is EUR
0.0836
+0.0020 (2.45%)
Aug 3, 2026, 12:37 PM CET

GenSight Biologics Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.650.652.632.964.877.71
Revenue Growth
-30.93%-75.16%-11.41%-39.10%-36.89%3.62%
Gross Profit
0.650.652.632.964.877.71
Operating Income
-11.05-11.05-15.81-29.7-27.84-28.13
Net Income
-12.04-12.04-14-26.22-27.63-28.62
Earnings Per Share
-0.08-0.08-0.15-0.54-0.60-0.63
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.422.422.462.1310.6144.29
Total Debt
17.8217.8219.1123.9317.8617.51
Net Cash (Debt)
-15.41-15.41-16.65-21.8-7.2526.78
Net Cash Growth
-----42.36%
Net Cash Per Share
-0.10-0.10-0.17-0.45-0.160.59

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9.17-9.17-12.94-24.66-33.75-17.14
Capital Expenditures
-0-0-0-0.01-0.25-0.03
Free Cash Flow
-9.17-9.17-12.94-24.67-34.01-17.17
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-1695.40%-1695.40%-602.40%-1002.23%-572.15%-364.85%
Pretax Margin
-1846.78%-1846.78%-532.57%-884.95%-416.67%-371.19%
Profit Margin
-1848.16%-1846.78%-532.57%-884.95%-416.57%-371.16%
FCF Margin
-1407.06%-1407.06%-492.88%-832.70%-698.97%-222.74%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
29.3535.289.8510.1432.0233.39